Across the United States, the healthcare sector accounted for approximately 47% of the jobs reported in April's jobs report.

The FDA's chief AI officer predicts that the agency's real-time clinical trial review pilot could potentially reduce overall trial duration by half.

There are currently 173 AI-originated drug programs in clinical development, none of which have yet received regulatory approval.